Literature DB >> 31860276

Transposing Lateral Flow Immunoassays to Capillary-Driven Microfluidics Using Self-Coalescence Modules and Capillary-Assembled Receptor Carriers.

Elisa Hemmig1, Yuksel Temiz1, Onur Gökçe1, Robert D Lovchik1, Emmanuel Delamarche1.   

Abstract

Point-of-care (POC) immunodiagnostic tests play a crucial role in enabling rapid and correct diagnosis of diseases in prehospital care, emergency, and remote settings. In this work, we present a silicon-based, capillary-driven microfluidic chip integrating two microfluidic modules for the implementation of highly miniaturized immunoassays. Specifically, we apply state-of-the-art microfluidic technology to demonstrate a one-step immunoassay for the detection of the cardiac marker troponin I in human serum using sample volumes of ∼1 μL and with a limit of detection (LOD) of ∼4 ng mL-1 within 25 min. The microfluidic modules discussed here broadly map functionalities found in standard lateral flow assays. We implement a self-coalescence module (SCM) for the controlled reconstitution and delivery of inkjet-spotted and dried detection antibodies (dAbs). This allows for homogeneous dissolution of 1.3 ng of fluorescently labeled dAbs in 416 nL of the sample used for the assay. We also show how to immobilize receptors inside closed microfluidic devices in <30 s using bead lane modules inside which microbeads functionalized with capture antibodies (cAbs) are self-assembled. The resulting bead lane module, with a volume of ∼3 × 10-5 mm3, is positioned across the flow path and holds ∼300 5 μm-diameter microbeads. Altogether, these capillary-driven elements allow for the manipulation of samples and reagents with an unprecedented precision and control, paving the way for the next generation of POC immunodiagnostics.

Entities:  

Year:  2019        PMID: 31860276     DOI: 10.1021/acs.analchem.9b03792

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  8 in total

1.  Handheld Microfluidic Filtration Platform Enables Rapid, Low-Cost, and Robust Self-Testing of SARS-CoV-2 Virus.

Authors:  Jiang Xu; Wenhao Suo; Youlian Goulev; Lei Sun; Liam Kerr; Johan Paulsson; Yan Zhang; Taotao Lao
Journal:  Small       Date:  2021-11-30       Impact factor: 13.281

2.  Pumpless three-dimensional photo paper-based microfluidic analytical device for automatic detection of thioredoxin-1 using enzyme-linked immunosorbent assay.

Authors:  Myeong-Jun Lee; Veasna Soum; Sang-Nam Lee; Jin-Ha Choi; Jeong-Hyeop Shin; Kwanwoo Shin; Byung-Keun Oh
Journal:  Anal Bioanal Chem       Date:  2021-11-12       Impact factor: 4.142

Review 3.  Lab-on-a-Chip Devices for Point-of-Care Medical Diagnostics.

Authors:  Sofia Arshavsky-Graham; Ester Segal
Journal:  Adv Biochem Eng Biotechnol       Date:  2022       Impact factor: 2.768

4.  Unraveling the Hook Effect: A Comprehensive Study of High Antigen Concentration Effects in Sandwich Lateral Flow Immunoassays.

Authors:  Georgina M S Ross; Daniel Filippini; Michel W F Nielen; Gert Ij Salentijn
Journal:  Anal Chem       Date:  2020-11-13       Impact factor: 6.986

5.  Development of Liposome-Based Immunoassay for the Detection of Cardiac Troponin I.

Authors:  Remya Radha; Mohammad Hussein Al-Sayah
Journal:  Molecules       Date:  2021-11-19       Impact factor: 4.411

6.  Capillaric field effect transistors.

Authors:  Claude Meffan; Julian Menges; Fabian Dolamore; Daniel Mak; Conan Fee; Renwick C J Dobson; Volker Nock
Journal:  Microsyst Nanoeng       Date:  2022-03-21       Impact factor: 7.127

Review 7.  Simplifying the complex: accessible microfluidic solutions for contemporary processes within in vitro diagnostics.

Authors:  Nathan K Khosla; Jake M Lesinski; Monika Colombo; Léonard Bezinge; Andrew J deMello; Daniel A Richards
Journal:  Lab Chip       Date:  2022-09-13       Impact factor: 7.517

Review 8.  Application of Microfluidics in Immunoassay: Recent Advancements.

Authors:  Yuxing Shi; Peng Ye; Kuojun Yang; Jie Meng; Jiuchuan Guo; Zhixiang Pan; Qiaoge Bayin; Wenhao Zhao
Journal:  J Healthc Eng       Date:  2021-07-15       Impact factor: 2.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.